Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

share price: (EoD)

earnings per share:

dividends per share:

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

ASX Bank Shares
James Dunn

S&P/ASX 200 (INDEXASX:XJO) starts the week in the green

The benchmark S&P/ASX 200 (INDEXASX: XJO) index adding 51.5 points, or 0.7 per cent, to 7124.7, with nine of the 11 sectors finishing in the green. The broader All Ordinaries (INDEXASX: XAO) index also rose 0.7 per cent, in its case 51 points, to 7,336.1.

Today's ASX news
Rask Invest Research Team

RMD and CSL Limited: 2 ASX shares to dig into

The Resmed CDI (ASX:RMD) share price has decreased 20.1% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price good value?’

Today's ASX news
Rask Invest Research Team

RMD and CSL Limited: 2 ASX shares to dig into

The Resmed CDI (ASX:RMD) share price has decreased 23.1% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price good value?’

Skip to content